CKBR-12 An Ibogaine Derivative Medicine For Parkinson’s
CKBR-12 is a Natural Ibogaine Derivative Medicine and Health Product (NHP) currently under evaluation as an anti-Parkinson medication. Developed by Genesis Parkinson’s Research Center a division of Genesis Parkinson’s[…]
Ibogaine Treatment for Parkinson’s Disease
More than 55 million people globally suffer from neurodegenerative illnesses, including Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease, with such conditions sadly being on the rise. Parkinson’s disease is[…]
The Long, Strange Trip of Rick PerryThe former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.
The Long, Strange Trip of Rick PerryThe former Texas governor and Trump energy secretary has now dedicated his life to promoting the powerful psychedelic ibogaine.Robert DraperBy Robert DraperReporting from[…]
Senate budget would fund first-in-the-nation study of Ibogaine treatment for opioid use disorder
Home / News Release / Senate budget would fund first-in-the-nation study of ibogaine treatment for opioid use disorder A proviso in the Washington Legislature’s supplemental operating budget would direct[…]
Understanding Ibogaine Treatment for Various Addictions
In today’s post, we will take an in-depth look at the complex labyrinth of human behavior. We’ll be shattering some illusions, and perhaps even a few delusions, about what[…]
How Ibogaine Rewires the Brain
The Day I Was Lobotomised by a Plant 15 minute read Much has been written in recent times about the benefits of psychedelic/oneiro genic plant medicines in treating addiction[…]
Powerful Psychedelic Gains Renewed Attention as a Treatment for Opioid Addiction
New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.[…]